MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, AIM had $1,871K increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$1,871K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Loss (gain) on sale of marketable investments
-18
Net loss
-3,284 -6,499
Depreciation of property and equipment
9 19
Abandonment and expiration of patents and trademark rights
82 615
Amortization of patent, trademark rights
45 94
Non-cash lease expense
-59 -81
Equity-based compensation
0 60
Gain on sale of marketable securities
17 -
Amortization of financial obligation
69 183
Change in fair value of warrants
-670 -
Loss on issuance of warrants
-3,977 0
Non-cash gain on settlement of liability
-3,041 -
Prepaid expenses and other current assets
-24 -9
Lease liability
-56 -78
Funds receivable from new jersey net operating loss
-0
Other assets
11 -761
Accounts payable
-2,570 914
Accrued expenses
287 -33
Net cash used in operating activities
-5,079 -3,892
Proceeds from sale of marketable securities
296 2,026
Purchase of marketable securities
0 91
(purchase) abandonment of patent and trademark rights
0 283
Net cash provided by investing activities
296 1,652
Proceeds from issuance of common stock and warrants
7,314 -
Proceeds from sale of stock, net of issuance costs
-398 765
Proceeds from note payable, net of issuance costs
0 250
Repayment of debt with cash
660 -
Proceeds from issuance of equity warrants
-0
Proceeds from equity line of credit
398 -
Net cash provided by financing activities
6,654 1,015
Net increase (decrease) in cash and cash equivalents
1,871 -1,225
Cash and cash equivalents at beginning of period
1,701 -
Cash and cash equivalents at end of period
2,347 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Inc. (AIM)